Literature DB >> 9883908

RNA aptamers that specifically bind to the Ras-binding domain of Raf-1.

M Kimoto1, K Sakamoto, M Shirouzu, I Hirao, S Yokoyama.   

Abstract

RNA aptamers that bind to the Ras-binding domain (RBD) of a proto-oncogene product, Raf-1, were isolated from a pool of random sequences using a glutathione S-transferase-fused RBD (GST-RBD). The RNA molecules bind to the GST-RBD, but not to GST, with dissociation constants of about 300 nM. In contrast, these RNA aptamers do not bind to the Ras-binding domain of the RGL protein, which is also known to be activated by Ras. The aptamers actually compete with Ras for binding to the Raf-1 RBD. The anti-Raf-1 aptamers may be used to specifically inhibit the Ras-Raf interaction in the complicated signaling network in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9883908     DOI: 10.1016/s0014-5793(98)01572-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  RNA aptamers and their therapeutic and diagnostic applications.

Authors:  Katherine Germer; Marissa Leonard; Xiaoting Zhang
Journal:  Int J Biochem Mol Biol       Date:  2013-03-31

2.  Aptamers that preferentially bind type IVB pili and inhibit human monocytic-cell invasion by Salmonella enterica serovar typhi.

Authors:  Qin Pan; Xiao-Lian Zhang; Hong-Yan Wu; Pan-Wen He; Fubin Wang; Ming-Sheng Zhang; Jian-Ming Hu; Bing Xia; Jianguo Wu
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

3.  RNA aptamers selectively modulate protein recruitment to the cytoplasmic domain of beta-secretase BACE1 in vitro.

Authors:  Andrea Rentmeister; Anke Bill; Tina Wahle; Jochen Walter; Michael Famulok
Journal:  RNA       Date:  2006-08-03       Impact factor: 4.942

4.  Lipid-mRNA Nanoparticle Designed to Enhance Intracellular Delivery Mediated by Shock Waves.

Authors:  Jing Zhang; Shamit Shrivastava; Robin O Cleveland; Terence H Rabbitts
Journal:  ACS Appl Mater Interfaces       Date:  2019-03-06       Impact factor: 9.229

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.